| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-06 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.12 | 1e-05 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.15 | 4e-05 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.14 | 5e-05 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.15 | 7e-05 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.12 | 9e-05 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0003 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.1 | 0.0003 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.17 | 0.0003 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.19 | 0.0004 |